ArticlePloS one2021

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.

Akira Madarame et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.